Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th September, 2026
Filed with HKEX · Stock code 1312 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorised share capital and provides details on issued shares and public float sufficiency. The report indicates that there were no changes in the number of issued shares during the month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Kontafarma China Holdings Ltd on 6ix
Earlier from Kontafarma China
- MAJOR TRANSACTION (Multi-Files)
- Notification letter to non-registered shareholders and request form - notification of publication of the circular of major transaction in relation to renewal of lease for fitness and yoga centre
- Grant of Waiver for further delay in despatch of circular under rule 14.41(a) of the listing rules
- Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
- Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr
Follow Kontafarma China into a list and get an email when it puts out news.
Follow Kontafarma China